HomeALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Previous close
$9.54
Day range
$9.54 - $9.59
Year range
$9.15 - $16.91
Market cap
2.73T JPY
Avg Volume
384.14K
In the news
Financials
Income Statement
Revenue
Net income
(JPY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 421.93B | 4.91% |
Operating expense | 327.17B | 23.00% |
Net income | 14.51B | -70.02% |
Net profit margin | 3.44 | -71.43% |
Earnings per share | — | — |
EBITDA | 65.85B | -22.30% |
Effective tax rate | 16.17% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 285.44B | -30.94% |
Total assets | 3.37T | 34.00% |
Total liabilities | 1.87T | 97.71% |
Total equity | 1.50T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | 1.36% | — |
Return on capital | 1.92% | — |
Cash Flow
Net change in cash
(JPY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 14.51B | -70.02% |
Cash from operations | 51.41B | -28.90% |
Cash from investing | -40.31B | -48.64% |
Cash from financing | -87.02B | -798.18% |
Net change in cash | -80.02B | -485.74% |
Free cash flow | 31.33B | 428.72% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. On February 5, 2020, the company announced management changes effective from April 1, 2020.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,484